Opaleye Management Inc.
Opaleye Management Inc., 10% owner at Grace Therapeutics, Inc., has 4 open-market purchases worth $424,421 in company stock reported to the SEC in the last two years. The latest filing was reported on 2026-10-26.
In plain English
- A 10%+ shareholder bought $117,408 of Grace Therapeutics, Inc. stock with their own money. A decent-sized purchase. (2026-10-26)
- A 10%+ shareholder bought $41,193 of Grace Therapeutics, Inc. stock with their own money. A small purchase, so treat it as a mild signal. (2026-10-26)
- A 10%+ shareholder bought $123,294 of Alpha Cognition Inc. stock with their own money. A decent-sized purchase. (2026-10-26)
- A 10%+ shareholder bought $142,526 of Alpha Cognition Inc. stock with their own money. A decent-sized purchase. (2026-10-26)
Filings
All insider buys · Legends · Executives
TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.